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Background: Royal jelly (RJ) is a proteinaceous secretion produced from the hypopharyngeal and mandibular
glands of nurse bees. It plays vital roles in honeybee biology and in the improvement of human health. However,
some proteins remain unknown in RJ, and mapping N-glycosylation modification sites on RJ proteins demands
further investigation. We used two different liquid chromatography-tandem mass spectrometry techniques,
complementary N-glycopeptide enrichment strategies, and bioinformatic approaches to gain a better
understanding of novel and glycosylated proteins in RJ.
Results: A total of 25 N-glycosylated proteins, carrying 53 N-glycosylation sites, were identified in RJ proteins, of
which 42 N-linked glycosylation sites were mapped as novel on RJ proteins. Most of the glycosylated proteins were
related to metabolic activities and health improvement. The 13 newly identified proteins were also mainly
associated with metabolic processes and health improvement activities.
Conclusion: Our in-depth, large-scale mapping of novel glycosylation sites represents a crucial step toward
systematically revealing the functionality of N-glycosylated RJ proteins, and is potentially useful for producing a protein
with desirable pharmacokinetic and biological activity using a genetic engineering approach. The newly-identified
proteins significantly extend the proteome coverage of RJ. These findings contribute vital and new knowledge to
our understanding of the innate biochemical nature of RJ at both the proteome and glycoproteome levels.
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Royal jelly (RJ) is a proteinaceous secretion derived from
the hypopharyngeal and mandibular glands of young
worker bees [1,2]. It is the sole food fed to the queen
throughout her lifetime, and is also fed to all young lar-
vae for the first three days after hatching [2]. RJ pos-
sesses various biological attributes beneficial for human
health, such as antioxidant activities [3], antibacterial ef-
fects [4], enhancement of immune activity [5], and anti-
tumor effects [6]. Protein accounts for >50% of RJ by dry
weight [2]. It has been reported that nine members of
major royal jelly proteins (MRJPs, MRJP1-9) [7,8] account
for 80-90% of the total protein in RJ [9]. Other proteins,
such as alpha-glucosidase, glucose oxidase, and alpha-
amylase have also been detected in RJ [1,10-12]. Although* Correspondence: apislijk@126.com
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stated.several studies have indicated that the proteins in RJ have
undergone glycosylation modification [12-16], we do not
yet know the types or site assignments of this glycopro-
tein. With the development of new technologies in protein
separation and identification, dozens of novel proteins
have been recently identified in RJ by our group and by
others [1,11,16,17]. Advances in resolution and sensitivity
(double high) of liquid chromatography-tandem mass
spectrometry (LC-MS/MS) have made it a powerful plat-
form. These advances have made it possible to profile the
proteome of RJ more deeply, while allowing for system-
level mapping of glycosylation sites of RJ proteins.
Asparagine-linked (N-linked) protein glycosylation is
the most abundant of all posttranslational modifications
in eukaryotes, with nearly 70% of all eukaryotic proteins
predicted to be N-glycoproteins [18]. N-linked glycosyla-
tion is an enzymatically catalyzed process that occurs in
the endoplasmic reticulum (ER). It involves the assembly
of glycans on a lipid carrier in the ER membrane, followed
by a transfer to specific asparagine residues of targetLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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tide backbone has been reported to assist in protein fold-
ing, stability, solubility, oligomerization, quality control,
sorting, and transport [20,21]. Glycoproteins mediate
many important biological processes by their involvement
in cell adhesion, cell differentiation, cell growth, and im-
munity [22,23].
To identify N-glycosylated peptides from the more
abundant non-glycosylated peptides in complex biological
samples, specific enrichment methods, such as lectin af-
finity [24] or hydrazide chemistry [25], are required before
they are subjected to double high LC-MS/MS analysis.
Since a consensus sequence motif of N-X-S/T exists in N-
glycosylation [20,21] (N = asparagine, X = any amino acid
except proline, S/T = serine or threonine), the digested as-
paragine residue in N-X-S/T resulting from deglycosyla-
tion of the enzyme (Peptide N Glycosidase, PNGase F,
commonly used) usually increases the mass by 0.98 Da.
This basic scientific evidence is used to locate the N-
glycosylation sites on a protein [26]. For more exact map-
ping of N-glycosylation sites, deglycosylation is usually
done by introduction of 18O-water (H2
18O), which in-
creases a mass shift in the MS spectra of 2.99 Da, thus
adding confidence to the site assignment [27].
It is well-known that mapping residue-specific glyco-
sylation sites is the first step towards a detailed and
functional understanding of proteins [20]. However, in-
formation on N-glycosylation site assignment in RJ pro-
teins is still very limited, thus demanding a powerful
glycoproteomics approach to large-scale comprehensive
mapping N-glycosylated sites in RJ proteins. Until now,
RJ proteins have been documented to contain a series of
glycoproteins [12,14,15], and are potentially glycosylated
by a gel stain [28]. Only MRJP 2 is reported to carry two
N-glycosylated sites attached a high-mannose structure
and complex type antennary structures [16].
In an effort to identify hidden proteins and to map the
N-linked glycosylation sites in RJ, two different double
high LC-MS/MS systems, Q-Exactive coupled to Easy-
nLC 1000 (orbitrap-based MS) and Triple TOF 5600
coupled with an Eksigent nLC (triple TOF-based MS), as
well as complementary glycopeptide enrichment protocols
(hydrazide and lectin), were employed. Overall, 25 N-gly-
cosylated proteins carrying 53 N-glycosylation sites were
confidently identified, of which novel 42 N-linked glyco-
sylation sites were mapped in RJ proteins, and 13 novel
proteins were identified in RJ.
Results
Identified novel royal jelly proteins
To expand the number of known proteins in the RJ prote-
ome, RJ proteins were extracted and digested with in-
solution methods and analyzed with double high LC-MS/
MS (orbitrap-based MS). A total of 42 nonredundantproteins were confidentially identified, of which 13 pro-
teins were novel (Table 1 and Additional file 1: Table S1).
The 42 identified proteins in RJ were classified on the
basis of their biological process and molecular function
and annotated by gene ontology. In the YELLOW/MRJP
family, a new protein, yellow-e3 precursor, was identi-
fied. Of the 12 proteins related to metabolic processes,
five novel proteins were identified: lysosomal pro-X car-
boxypeptidase, lysosomal aspartic protease, membrane
metallo-endopeptidase 1, matrix metalloproteinase 14, and
pancreatic triacylglycerol lipase. Among the 14 proteins
associated with health improvement, six were reported
here for the first time: venom dipeptidyl peptidase 4
precursor, venom serine protease 34, hymenoptaecin pre-
cursor, venom protease, hypothetical protein LOC408570,
lysozyme isoform 1. One of the four proteins involved in
development processes was novel, protein CREG 1 (Table 1
and Additional file 1: Table S1). Interestingly, the majority
of the newly-identified proteins were related both to
metabolic processes (accounting for 38.5% of all novel
proteins) and health promotion activities (46.2% of all
novel proteins).
Mapping N-glycosylated sites
To attain a comprehensive map of N-linked glycosyla-
tion sites in RJ, RJ proteins were extracted and enriched
by two different enrichment methods (hydrazide and
lectin), after which the N-glycosylation peptides were ana-
lyzed by two different double high LC-MS/MS (orbitrap-
based MS and triple TOF-based MS). The introduction of
18O-water in the process of PNGase F digestion added to
confidence to the identification of N-glycopeptides. An ex-
ample spectrum of N-glycopeptide is shown in Figure 1
(for all other spectra see Additional file 2: Figure S1). Over-
all, 25 N-glycoproteins carrying 53 unique N-linked glyco-
sylation sites represented 60% of the total identified
proteins in RJ. Among the 53 identified N-linked glycosyla-
tion sites, 42 were confidentially mapped in RJ proteins for
the first time (Table 2).
In the YELLOW/MRJP family, seven proteins were iden-
tified as N-glycoproteins, glycosylated on 12 unique pep-
tides, each carrying a single N-glycosylated site (Table 2).
Of the proteins involved in metabolic processes, seven
were N-glycosylated on 16 unique N-glycopeptides: all but
on each contained a single N-glycosylation site and one
unique N-glycopeptide carried two sites (Table 2). Of the
proteins related to health improvement, seven were found
N-glycosylated on 18 unique peptides, and each peptide
had a single N-glycosylated site (Table 2). Of the two
proteins implicated in the regulation of morphological de-
velopment, IDGF 4 was N-glycosylated on one unique
peptide with a single site, and N-glycosylated protein take-
out had one unique peptide carrying two sites (Table 2).
Finally, two identified N-glycoproteins with unknown
Table 1 Identification of proteins in royal jelly
Classification Accession -10lgP Coverage (%) Matches Unique Mass(Da) Protein name SignalP PSORT
YELLOW/MRJP family
gi|58585098 566.72 96 742 166 48886 Major royal jelly protein 1
precursor
- -
gi|58585108 527.66 93 437 100 51074 Major royal jelly protein 2
precursor
- -
gi|58585142 487.03 88 354 12 61662 Major royal jelly protein 3
precursor
- -
gi|284182838 357.38 89 236 15 53015 Major royal jelly protein 4 - -
gi|284812514 386.92 71 182 6 70182 Major royal jelly protein 5 - -
gi|58585188 282.69 58 57 7 49786 Major royal jelly protein 6
precursor
- -
gi|62198227 422.37 84 182 70 50541 Major royal jelly protein 7
precursor
- -
gi|58585070 131.13 15 3 3 46956 Major royal jelly protein 8
precursor
- -
gi|67010041 221.7 45 26 10 48688 Major royal jelly protein 9
precursor
- -
gi|148277624 146.46 19 6 6 48235 Yellow-e3 precursor* √ #
Metabolic activity
gi|328787887 299.74 26 40 37 188194 Lysosomal alpha-
mannosidase
- -
gi|89885579 290.12 50 33 3 65565 Alpha-glucosidase - -
gi|58585144 227.31 43 7 3 55947 Alpha-amylase precursor - -




gi|328778095 116.42 10 4 4 56432 Lysosomal Pro-X
carboxypeptidase*
√ #
gi|66560290 102.39 10 3 3 42222 Lysosomal aspartic
protease*
√ #
gi|328782027 93.88 6 4 4 88720 Membrane metallo-
endopeptidase 1*
√ #
gi|48118838 276.66 56 32 31 58571 Glucosylceramidase - -
gi|66524161 196.85 59 15 14 25186 Ferritin heavy chain - -
gi|328779534 220.38 10 23 20 79344 Hypothetical protein
LOC552041
- -
gi|328780642 167.48 16 9 8 64654 Matrix metalloproteinase
14*
√ #




gi|58585090 389.52 76 137 77 67938 Glucose oxidase - -
gi|166795901 259.92 93 46 14 21348 Apolipophorin-III protein
precursor
- -
gi|328782084 240.41 41 7 4 59502 Antithrombin-III - -
gi|60115688 226.26 71 39 5 24819 Icarapin precursor - -
gi|254910938 214.17 75 14 4 10717 Defensin-1 preproprotein - -
gi|187281543 150.07 16 11 10 87937 Venom dipeptidyl
Peptidase 4 precursor*
√ #
gi|110755367 142.44 13 7 7 75706 Toll-like receptor 13
isoform 1
- -
gi|48101366 138.63 15 5 5 44639 Venom serine protease
34*
√ #
gi|254548157 102.39 37 3 2 12611 Hymenoptaecin
precursor*
√ #
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Table 1 Identification of proteins in royal jelly (Continued)
gi|328790726 243.78 70 28 19 42665 Venom acid phosphatase
Acph 1
- -
gi|66507455 188.31 27 11 11 39483 Venom protease* √ #
gi|328792524 89.27 9 5 2 90763 Hypothetical protein
LOC408570*
√ #
gi|110758964 221.47 83 17 4 10161 Regucalcin - -
gi|66565246 83.06 16 3 2 17081 Lysozyme isoform 1* √ #
Developmental process
gi|66514614 165.33 19 8 4 48741 Idgf4 - -
gi|110766389 139.29 22 5 5 30201 Protein takeout - -
gi|66521538 101.17 11 2 2 33735 Protein CREG1* √ #




gi|48094573 292.99 64 45 32 19434 Hypothetical protein
LOC408608
- -
gi|110763647 109.47 27 5 4 18478 Hypothetical protein
LOC726323
- -
Note: All of the identified proteins are of Apis mellifera origin. Accession is the unique number given to mark the entry of a protein in the database of Apis
(downloaded April 2012, version 4.5 of the honeybee genome) using in-house PEAKS software (version 6.0, Bioinformatics Solutions Inc.). “-10logP” is the score
calculated by PEAKS software. Sequence coverage is the ratio of the number of amino acids in every peptide that matches with the mass spectrum divided by the
total number of amino acids in the protein sequence. Matches are the number of experiment fragmentation spectra paired to a theoretical segment of protein.
The number of unique peptides refers to the peptide sequences that are unique to an individual parent protein sequence. SignalP refers to the result researched
with SignalP 4.1. PSORT refers to the result researched with PSORT II. “*” indicates the protein identified as novel in royal jelly. “√” indicates the protein identified
with signal peptide by SignalP 4.1. “#” indicates the protein identified as extracellular by PSORT II. “-” indicates the protein did not be researched with SignalP 4.1
or PSORT II.
Figure 1 Representative spectra of N-glycosylated peptide in royal jelly proteins. The tandem mass spectrum of the N-glycosylated site is
identified in peptide GESLN(+2.99)KSLPILHEWK using 18O-water labeling.
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Table 2 Identification of glycosylated proteins, peptides and their glycosylation sites in royal jelly proteins
Accession Glycoprotein and
glycopeptide














gi|58585098 Major royal jelly protein 1
precursor
442.09 48886
R.GESLN(+2.99)KSLPILHEWK.Fb 57.82 585.32 3 8 24-38 28 √ √





67.92 797.42 3 15 162-183 178 √ √ √ √
K.IAIDKFDRLWVLDSGLVN
(+2.99)R.Ta
57.57 1117.1 2 9 128-146 145 √ √ √ √
gi|284182838 Major royal jelly protein 4 298.73 53015
R.KN(+2.99)LTNTLNVIHEWK.Yb 57.71 856.97 2 5 30-41 31 √ √
K.M(+15.99)SNQQEN(+2.99)
LTLKEVDNK.Vb
47.23 637.31 3 2 236-251 242 √ √
gi|58585188 Major royal jelly protein 6
precursor
203.5 49786
K.NYPFDVDQWHN(+2.99)K.Td 47.63 783.35 2 4 68-79 78 √ √
K.LLAFDLN(+2.99)TSKLLK.Qd 47 739.94 2 2 158-170 164 √





54.49 1006 2 11 168-185 178 √ √ √ √
R.LWVLDSGLVN(+2.99)NTQPM
(+15.99)C(+57.02)FPK.Ld




57.66 1447.2 2 2 312-316 321 √
gi|67010041 Major royal jelly protein 9
precursor
107.71 48688
K.IPHDIAIN(+2.99)STTGK.Rd 40.14 685.37 2 2 170-182 177 √
gi|148277624 Yellow-e3 precursor 89 48235
K.YM(+15.99)SGTLNSN(+2.99)
ETNFR.Ie







53.93 877.38 3 4 538-558 557 √ √
R.LLKDDAFGVGEALN(+2.99)
ESAYGEGLVVR.Gd
50.85 1313.2 2 2 722-746 735 √
gi|89885579 Alpha-glucosidase 193.65 65565
K.N(+2.99)VSRDSN(+2.99)
SSDFKK.Lb
39.74 497.24 3 2 313-325 313 319 √
K.HM(+15.99)LIEAYTN(+2.99)
LSM(+15.99)TM(+15.99)K.Yb
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Table 2 Identification of glycosylated proteins, peptides and their glycosylation sites in royal jelly proteins (Continued)
K.ESADYGLENVHGEN(+2.99)
VTVPFWVR.Gd
63.89 1261.1 2 2 99-120 112 √
R.SVTPYSLYTPHTGHQSYGEN
(+2.99)VTK.Id
55.98 643.06 4 5 212-234 231 √ √
R.IM(+15.99)TLLSPM(+15.99)
GN(+2.99)LTVR.Sd
42.7 790.92 2 3 394-407 403 √ √
R.AIM(+15.99)NEALN(+2.99)
GSFK.Gd
















50.01 592.55 4 2 92-111 110 √
K.WYDN(+.98)SGVN(+2.99)
TSTAK.Ie
37.35 723.83 2 1 311-323 318 √
R.IVNTN(+2.99)DTETR.Le 36.04 583.28 2 1 31-40 35 √
gi|48118838 Glucosylceramidase 142.8 58571
K.QFDNN(+2.99)
ITYLKEEHYETYVNYLIK.Fd
54.42 735.86 4 3 211-233 215 √ √
K.N(+2.99)FSLAPEDYNYK.Id 46.71 732.33 2 2 171-182 171 √
K.TQANWIANYFGPILASSPFN
(+2.99)K.Td
30.3 781.41 3 1 273-293 292 √
R.M(+15.99)N(+2.99)
VSEVKFDR.Cd
40.85 622.3 2 3 72-81 73 √ √ √
gi|58585090 Glucose oxidase 277.69 67938
R.SNLHVIVN(+2.99)ATVTK.Vd 54.93 699.9 2 8 277-289 284 √ √ √ √
K.LVN(+2.99)TTVM(+15.99)
RDLGVEFQK.Id




40.6 1180.9 3 4 172-200 194 √ √
R.AFITPFEN(+2.99)R.Sd 41.19 549.28 2 3 268-276 275 √ √
K.YYTTN(+2.99)
ESHACLSTGGSCYWPR.Gd






62.84 857.76 3 6 71-92 86 √ √ √
gi|328782084 Antithrombin-III 97.9 59502
K.ISN(+2.99)
DSAQNGERDSIYHLIER.Ld




R.HLAFATFN(+2.99)DTNVR.Dc 47.19 503.59 3 2 232-244 239 √
R.ANSFN(+2.99)GTWK.Tc 39.89 514.24 2 2 64-72 68 √
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Table 2 Identification of glycosylated proteins, peptides and their glycosylation sites in royal jelly proteins (Continued)
K.YSWIDSN(+2.99)R.Tc 34.35 522.24 2 2 625-632 631 √





55.39 981.48 2 2 547-563 555 √
R.HLNTQFFHN(+2.99)TTNLNK.
Ld
54.76 611.31 3 2 166-180 174 √
K.LHTLEEGLFAN(+2.99)LTR.Ld 50.96 539.62 3 2 432-445 442 √
R.LSEEAFKN(+2.99)ASK.Ld 39.92 613.81 2 1 315-325 322 √











43.11 824.45 2 2 539-553 547 √
R.QN(+2.99)YTDAPPAK.Le 41.13 554.27 2 2 590-599 591 √
R.IDPN(+2.99)SSFTQSNPIR.Fe 38.14 789.89 2 2 284-297 287 √ √
gi|66514614 Idgf4 135.8 48741
R.LKDLTIGVLPHVN(+2.99)
STVYYDAR.Ld
57.43 595.07 4 2 216-236 228 √
gi|110766389 Protein takeout 90.9 30201
R.ALFSN(+2.99)ITVIGAGN
(+2.99)YSLTK.Sd










R.IYDPITN(+2.99)TSK.Md 35.5 577.8 2 1 133-142 139 √
Note: All of the identified proteins are from Apis mellifera. Accession is the unique number given to mark the entry of a protein in the database of Apis
(downloaded April 2012, version 4.5 of the honeybee genome). “-10logP” is the score calculated by PEAKS software (version 6.0, Bioinformatics Solutions Inc.).
Charge is the number of the carrying charge of the peptide. No. of spectra is the number of the spectrum of the peptide generated by mass spectrometry. Amino
acid residue No. corresponds to the position of the N-terminal and C-terminal amino acid of the peptide in the protein sequence. Glycosylation site indicates the
position of the N-glycosylated amino acids of the peptide in the protein sequence. Orbitrap refers the peptides analyzed by the Q-Exactive mass spectrometry
(Thermo Fisher Scientific). Triple TOF refers the peptides analyzed by Triple TOF 5600 (AB SCIEX). Lectin denotes N-glycopeptides enriched by the lectin method.
Hydrazide represents N-glycopeptides enriched by hydrazide chemistry. “√” indicates that peptide is identified by the corresponding enrichment method and
mass spectrometer. “a” is the known site in the known protein. “b” is the potential site (bioinformatics has predicted these potential sites in UniProt Database
(updated April 2013), and it is experimentally confirmed in this study) in the known protein. “c” is the potential site in the novel protein. “d” denotes the novel site
in the known protein. “e” is the novel site in the novel protein.
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N-glycosylated site (Table 2).
Among those 53 unique N-glycosylated sites, 21 were
identified by lectin enrichment alone, eight were uniquely
identified by the hydrazide enrichment, and 18 were iden-
tified by both enrichment methods using orbitrap-based
MS (Figure 2A). Similarly, eight N-glycopeptides were
specifically identified by the lectin enrichment protocol,
two were specifically identified by the hydrazide chemis-
try, and six were identified by both enrichment methods
using triple TOF-based MS (Figure 2B). In general, 29
N-glycopeptides were uniquely identified by orbitrap-based MS, four were uniquely identified by triple TOF-
based MS, and 10 were identified by both MS systems
using the lectin enrichment method (Figure 2C). Likewise,
18 N-glycopeptides were identified by orbitrap-based
MS alone, and eight were identified by both types of
LC-MS/MS instruments with adoption of hydrazide en-
richment (Figure 2D).
As shown in Figure 3 and Table 2, the distribution of the
53 N-glycosylated sites was subdivided into known and
novel proteins. Specifically, only two known sites in known
glycoproteins were repeatedly identified in the current
study, and six potential sites in known glycoproteins and
Figure 2 Distribution of N-glycopeptides analyzed by different
enriched methods and instruments of royal jelly proteins. A is the
distribution of N-glycopeptides enriched by lectin and hydrazide
methods using mass spectrometry of Q-Exactive (orbitrap-based MS).
21 and eight are N-glycopeptides uniquely identified by the lectin and
hydrazide enrichment, respectively, and 18 are N-glycopeptides
identified by both enrichment methods using orbitrap-based MS. B is
the distribution of N-glycopeptides enriched by lectin and hydrazide
methods using mass spectrometry of triple TOF 5600 (triple TOF-based
MS). Eight and two are N-glycopeptides specifically identified by the
lectin and hydrazide enrichment protocols, respectively, and six are
N-glycopeptides identified by both enrichment methods using triple
TOF-based MS. C is the distribution of N-glycopeptides identified
by the orbitrap-based MS and triple TOF-based MS using lectin
enrichment method. 29 are N-glycopeptides uniquely identified by
orbitrap-based MS, and four are uniquely identified by triple TOF-based
MS, and 10 are N-glycopeptides identified by both MS systems using
the lectin enrichment method. D is the distribution of N-glycopeptides
identified by orbitrap-based MS and triple TOF-based MS using hydra-
zide enrichment. 18 are N-glycopeptides identified by orbitrap-based
MS alone, and eight are N-glycopeptides identified by both types of
LC-MS/MS instruments with adoption of hydrazide enrichment.
Figure 3 Distribution of N-glycosylated sites in royal jelly proteins. “2
potential sites predicted in known glycoprotein, and “3” is potential glycos
identified in known glycoprotein, and “9” is the novel sites identified in nov
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fied. The potential sites predicted in the UniProt Database
(updated April 2013) were also experimentally con-
firmed in this study. Thirty-three novel sites were iden-
tified in known glycoproteins, and nine novel sites in
novel glycoproteins.
Site occupancy analyses showed that approximately 48%
of N-glycosylated proteins carrying a single N-linked gly-
cosylated site, 20% contained two sites, 16% retained three
sites, and the rest carried four or more N-glycosylated
sites (Figure 4).
To gain a better understanding the sequence motif of the
N-linked glycosylation site in RJ, the surrounding sequences
(five amino acids to both termini) of N-glycosylated sites
were compared. As shown in Figure 5, about two-thirds
were the N-X-T motif and the others were the N-X-S motif
in the downstream (positive values) of N-linked modifi-
cation sites. In other words, the N-linked sequence
motif was X-X-N-X-S/T-X in N-glycoproteins of RJ
(N = asparagine, X = any amino acid except proline,
S/T = serine or threonine).Discussion
To gain a new understanding of innate biochemical prop-
erties of RJ at the proteome and glycoproteome levels, RJ
was analyzed for the identification of novel proteins hid-
den in RJ and mapped for N-glycosylation sites using the
double high LC-MS/MS system (orbitrap and triple TOF)
and complementary methods of glycoprotein/glycopep-
tides enrichment (hydrazide chemistry and lectin). Over-
all, 13 novel proteins and 42 novel N-glycosylated sites in
25 N-glycosylated proteins were identified.” is the identified two known sites in known glycoprotein. “6” is
ylation sites identified in novel glycoprotein. “33” is the novel sites
el glycoprotein.
Figure 4 Distribution of N-glycosylated royal jelly proteins
carrying different numbers of modification sites. “1, 2 and 3” are
the N-glycosylated protein carrying 1, 2 and 3 N-linked glycosylation
sites, respectvely. “> = 4” is the N-glycosylated protein carried four or
more N-glycosylated sites.
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The exploration of novel proteins in RJ is a long-term
pursuit for apicultural biologists and biochemical ex-
perts. The fast improvement of MS with high resolution,
high mass accuracy, and high sequencing speed now al-
lows for in-depth identification of proteins in a compre-
hensive and unbiased manner in biological samples with
high confidence. Compared with previous reports and
bioinformatics analysis [1,11,17,28,29], 13 novel proteins
were identified in this study. To establish the confidence
that the newly identified proteins were real secretory pro-
teins and not contaminated cellular proteins that may
have leaked during secretory process of RJ glands, we used
two bioinformatics software programs to confirm the ori-
gination of the secretory proteins. Proteins predicted as
extracellular proteins by PSORT indicate they are putative
secretory proteins [30]. To confirm this, SignalP was used
to verify the presence of N-terminal secretory signal pep-
tides [31]. This method suggested that all of the 13 novel
proteins predicted to be secretory proteins are real protein
components of RJ. They are mainly involved in metabolic
processes and health promotion activities. This finding isFigure 5 N-glycosylated site motif in royal jelly proteins.of particular importance for opening new doors to under-
standing how RJ accomplishes its roles in honeybee biol-
ogy and in the promotion of human health.
The YELLOW/MRJP is the most important RJ protein
family and plays key roles both in honeybee biology and
the promotion of human health [9]. The amazing fecund-
ity of the queen (one queen lays 1,500-2,000 eggs a day,
more than her body weight [2]) and the exponential speed
of larval growth (weight increase by 1,600 times in the first
six days of growth [32]) are achieved by a diet of highly-
nutritious RJ. MRJPs share a common evolutionary origin
with the yellow protein family [33,34]. In particular, yel-
low-e3 and mrjp genes share the most introns/exons in
the same relative positions [33]. The gene expression of
yellow-e3 in the honeybee head and hypopharyngeal
glands almost completely coincides with a developmental
pattern typical of mrjp genes, supporting that yellow-e3 is
the most recent common ancestor of the MRJP families
[33,34]. Therefore, the newly identified yellow-e3 precur-
sor in RJ is likely to act in a similar manner to that of the
MRJPs, performing multifunctional roles in supplying
nutrition and modulating caste determination of the hon-
eybee [34,35]. Noticeably, in previous RJ studies, only
MRJP1-5 have been repeatedly identified by a singular
proteomics protocol [1,12,17,28]. MRJP6-9 are identified
only when special technology is used [8,11]. For ex-
ample, identification of MRJP8 requires a special diges-
tion method for the proteins [28]. In this study, we not
only identified MRJP1-9 in a single study, but we also
identified yellow-e3 precursor as a new member of the
YELLOW/MRJP family. This indicates that our protocol
has a high efficiency in identification of RJ proteins.
RJ provides efficient energetic fuels for the fast devel-
opment of larvae and the egg-laying queen through the
metabolism of sugars, lipids, and proteins [2]. The iden-
tification of a high number of proteins related to the me-
tabolism of sugar, lipids, and proteins suggests that the
honeybee has an evolutionary strategy of using RJ to fulfill
the enormous energy requirement of the fast-developing
larvae and the egg-laying queen through these metabolic
pathways. Noticeably, five of the 13 novel proteins identi-
fied were associated with this category, indicating their
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suring the normal growth of honeybee larvae. Triacylglyc-
erol lipase breaks down dietary fat, mainly triacylglycerol,
to monoacylglycerol, and free fatty acids to supply the
energy requirements of living organisms [36]. In addition,
enzymes of lysosomal pro-x carboxypeptidase, lysosomal
aspartic protease, membrane metalloendopeptidase, and
matrix metalloproteinase 14, also participate in the metab-
olism of protein to produce energy [37,38].
RJ has been well to documented enhance immunity for
honeybees and to promote health for humans [2]. Among
the 14 RJ proteins related to health promotion activities,
six were identified as novel. Dipeptidyl peptidase IV is
known to functionally suppress peritoneal dissemination
and the progression of ovarian carcinoma, inhibit the ma-
lignant phenotype of prostate cancer cells, and promote
the human immune system [39,40]. Venom serine protease
34 is part of a defense mechanism against intruding micro-
organisms and parasites in insects [41-43]. Hymenoptaecin
can inhibit the viability of gram-positive and gram-negative
bacteria, and provides wide-spectrum antibacterial protec-
tion for honeybees and humans [44,45]. Venom protease
has fibrinogenolytic activity and is a strong antithrombotic
agent in snakes [46]. Lysozyme isoform 1 is an important
member related to the innate immunity of insects, effi-
ciently protecting larvae from diseases and pests [47].
The hypothetical protein LOC408570 (93% homology
with peroxidasin protein of Harpegnathos saltator) [48]
has functions in phagocytosis and in defense against
radioiodinations and oxidation [49].
The newly identified protein cellular repressor of E1A-
stimulated genes (protein CREG) might contribute to
the promotion of differentiation of honeybee larvae by
the enhancement of cell differentiation [50] as MRJP 1
does [51].
Mapping N-glycosylated sites
By using two complementary enrichment protocols (hy-
drazide chemistry and lectin resin) and two orbitrap-
based and triple TOF-based double high LC-MS/MS
systems, we have achieved an in-depth identification of
25 N-glycoproteins that mapped on to 53 sites on RJ
proteins. Among these, 42 novel N-linked glycosylation
sites were reported in RJ proteins. To the best of our
knowledge, this is the most comprehensive assignment
of the N-glycosylated sites of RJ.
Capturing the maximum number of glycopeptides is of
great importance for the analysis of mapping glycosyl-
ated sites [52,53], and is achievable using the comple-
mentary enrichment of glycopeptides with techniques
such as hydrazide chemistry and lectin based protocols.
Hydrazide chemistry can efficiently capture glycoproteins
once oxidized by sodium periodate, and is thus extremely
useful for the identification of glycopeptides [54]. “Filteraided sample preparation” (FASP) is an N-glycopeptide en-
richment protocol that uses a combination of different lec-
tins to efficiently capture glycopeptides [55]. By adopting
two different methods based on lectin and hydrazide en-
richment, comprehensive glycosylation sites were assigned
in RJ, namely 46 by lectin resin and 16 by hydrazide chem-
istry. Meanwhile, orbitrap-based MS seems to be more ro-
bust than Triple TOF-based MS in the identification of
glycosylated sites in RJ, and the combined utilization of
two different double high LC-MS/MS yielded identification
of more number of N-glycosylated sites in RJ. Together, of
the 53 N-glycosylation sites assigned in RJ proteins, 42
were mapped as novel. Nine potential N-glycosylation sites
predicted by the Uniprot database (updated April 2013)
were also verified. In addition, the only two known
N-glycosylation sites [16] were repeatedly identified.
It is now known that blocking glycosylation could re-
sult in improper or incomplete folding of many polypep-
tides. These improperly folded polypeptides would not
passing ER quality control [56] and would be retained in
the ER and eventually degraded [57]. Given that RJ pro-
teins contain 80-90% of MRJPs [9], glycosylation may help
MRJPs reach their native conformation to accomplish
their biological roles for both honeybees and humans [9].
Glycosylation also allegedly increases the solubility of pro-
teins [58,59]. Therefore, the glycosylated YELLOW/MRJPs
suggest their roles in promoting the solubility of YEL-
LOW/MRJPs in RJ to enhance their nutritive efficiency of
assimilation [60,61]. Since glycosylated proteins have roles
in immunity [62], the weak immunity of the young honey-
bee larvae (the first 48 h) may be promoted by feeding gly-
cosylated MRJPs to ensure normal development [63]. This
is in line with report that glycosylated MRJP 2 can effect-
ively inhibit Paenibacillus larvae infection [16].
Glycosylation site occupancy modulates enzymatic activ-
ities by the attachment of glycans to peptide backbones
[64]. Interestingly, the majority of glycosylated proteins
identifed here are enzymes associated with the metabolic
pathways of carbohydrates and proteins. For instance, three
enzymes, lysosomal alpha-mannosidase, alpha-glucosidase,
and glucosylceramidase, are involved in carbohydrate me-
tabolism [65-67]. Four other enzymes, plasma glutamate
carboxypeptidase, lysosomal pro-x carboxypeptidase, lyso-
somal aspartic protease, and membrane metalloendopepti-
dase, are implicated in the metabolism of proteins [37,38].
The high number of glycosylated proteins related to meta-
bolic processes indicates the production of enough energy
through the metabolism of carbohydrates and proteins for
queen spawning and larval growth, which may be achieved
by modulating the enzymatic efficiency [64].
N-glycosylation modification of proteins has reported
to improve the health of living organisms through anti-
bacterial activity [68], antioxidant activity [69], and anti-
hypertension [70]. For instance, glucose oxidase acts as a
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to a hydrogen peroxide formation [71]. Venom dipeptidyl
peptidase 4 precursor could enhance immune response
activity by stimulating the T-cells of mammalia [39,40].
Antithrombin-III, Apolipophorin-III protein precursor, and
toll-like receptor 13 all play key roles in promoting the in-
nate immunity of honeybee larvae [11,72-77]. MRJP 1 has
potential antitumor effects by stimulating macrophages to
release TNF-α [61]. In addition, the glycosylated protein af-
fects cell proliferation and regulates circadian rhythm [78].
Chitinase, as a growth factor, stimulates the proliferation
and polarization in Drosophila [79]. Protein takeout helps
regulation of circadian rhythms and feeding behavior in
Drosophila [80]. Overall, the glycosylation of these RJ pro-
teins suggests that they may be involved in the above bio-
logical roles benefitting both honeybee and humans.
An oligosaccharide unit attached to the polypeptide at
the site of occupancy has reported to improve solubility,
folding, and half-life of the glycoprotein [81]. Most
glycosylated RJ glycoproteins (~ 50%) carried a single
N-glycosylation site, ~ 20% carried two or three sites,
and only a few carried four or five sites. In addition, the
identified conservative motif of amino acid sequence of
N-glycosylated RJ peptides may have structural and
functional importance for RJ proteins in future studies
[82,83]. Although the glycan linkages associated with the
glycosylation sites demand further investigation, this new
catalog of knowledge may prove helpful in elucidating the
biological implications of glycosylation for the RJ proteins
through synthesizing the glycan to the identified sites.
This is possible because N-glycosylation is a conserved
process of post-translational modification in a diversity of
proteins in eukaryotic organisms [18], and the established
N-linked glycosylation system in the Campylobacter sys-
tem could transfer a functional N-linked glycoprotein into
Escherichia coli [84]. This provides promising glycoengi-
neering possibilities for producing modified RJ peptides
that could produce a protein with desirable pharmacokin-
etics and biological activity.
Conclusions
A total of 13 novel proteins and 42 novel N-linked gly-
cosylation sites in 25 N-glycosylated RJ proteins have
been identified here. Of the glycosylated proteins, most
were related to metabolic activities and carry multiple
N-linked glycosylation sites. This is important for young
larvae and the fertile egg-laying queen, since their high
metabolic fuel demands may be achieved through the regu-
lation of the enzymatic activities related to the metabolic
process. The glycosylated proteins related to the improve-
ment of human health suggest N-glycosylation plays a key
role in helping RJ proteins accomplish their biological
functions. The large scale assignment of N-glycosylated
sites represents a crucial first step toward systematicallyrevealing the functionality of N-glycosylated RJ proteins. In
addition, the identification of novel proteins mainly associ-
ated with metabolic process and promoting human health
significantly extend the proteome coverage of RJ.
Methods
Sample preparation
RJ was collected as a pooled samples from 250 queen cell
cups from each of five colonies of Apis mellifera ligustica
at the apiary of the Institute of Apicultural Research,
Chinese Academy of Agricultural Science, Beijing. RJ pro-
teins were extracted immediately after harvest according
to previously described methods [72]. The resulting pellets
were divided into three parts for the following analyses.
In-solution digestion
The first part of the above protein pellets (1 mg RJ/100 μl
buffer) was dissolved in 40 mM of (NH4)HCO3 (Sigma).
The sample was used for in-solution digestion (trypsin,
modified sequencing grade, Promega) according to our
previous methods [72]. Finally, the peptide-containing
solution containing peptides was concentrated using a
Speed-Vac system (RVC 2-18, Marin Christ) for MS/MS
analysis.
N-linked glycopeptide enrichment with hydrazide
chemistry
The second part of the protein pellet (1 mg RJ/100 μl
buffer) was suspended in a coupling buffer [100 mM so-
dium acetate (Sigma), 150 mM NaCl (Sigma), pH 5.5] and
then prepared by enriching the N-linked glycopeptides
with hydrazide resin according to the method of Zhang et
al. [54]. Briefly, the glycoproteins were oxidized, and these
oxidized proteins were captured by hydrazide resin (Bio
Rad). The captured glycoproteins were digested overnight
by trypsin. Afterwards, the digested glycopeptides were
further digested by PNGase F (NEB) to remove the gly-
cans attached to the proteins, and were labeled by H2
18O
(Sigma) to confidently assign the N-glycosylation sites. Fi-
nally, the collected supernatant was concentrated using a
Speed-Vac system for MS/MS analysis.
N-linked glycopeptide enrichment with lectin
The remaining third of the protein pellets (1 mg RJ/
100 μl buffer) was suspended in 8 M of urea in 100 mM
of Tris-HCl (pH 8.5) and the mixture was transferred
into an Ultracel YM-10 10,000 MWCO centrifugal filter
unit (Millipore) and digested by trypsin overnight. Fol-
lowing this, the digested peptides were prepared for
enrichment by the N-linked glycopeptides with lectin
(mixture with Concanavalin A, wheat germ agglutinin,
and RCA120 agglutinin) (Sigma) and a second digestion
by PNGase F and H2
18O, labeled according to N-Glyco-
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centrated using a Speed-Vac system for MS/MS analysis.
Mass spectrometric analysis
The three peptide samples were analyzed on the Q-
Exactive mass spectrometer (Thermo Fisher Scientific)
coupled to an Easy-nLC 1000 (Thermo Fisher Scientific)
via a nanoelectrospray ion source. Full MS scans were
acquired with a resolution of 70,000 at m/z 400 in the
orbitrap analyzer. The 20 most intense ions were frag-
mented by higher energy collisional dissociation (HCD).
The HCD fragment ion spectra were acquired in the
orbitrap analyzer with a resolution of 17,500 at m/z 400.
Reverse phase chromatography was performed with a
binary buffer system consisting of buffer A (0.1% formic
acid, 2% acetonitrile in water) and buffer B (0.1% formic
acid in acetonitrile). The peptides were separated with a
flow rate of 350 nl/min in the EASY-nLC 1000 system
by the following gradient program: from 3 to 8% buffer
B for 5 min, from 8 to 20% buffer B for 55 min, from 20
to 30% buffer B for 10 min, from 30 to 90% buffer B for
5 min, and 90% buffer B for 15 min.
To obtain a comprehensive map of N-glycosylation
sites in RJ proteins, the glycopeptide samples were also
analyzed by electrospray ionization, quadruple time-of-
flight system (Triple TOF 5600, AB SCIEX) coupled with
an Eksigent nano liquid chromatography system (Eksigent
Technologies). Separation was performed using a self-
packed in-house 150 × 0.075 mm 300A pore C18 column,
at a flow rate of 330 nl/min. The peptides were eluted with
a spectral acquisition speed of 20 MS/MS per second,
using the following gradient program: from 5 to 8% buffer
B (0.1% formic acid in acetonitrile) for 0.1 min, from 8 to
30% buffer B for 22 min, from 30 to 48% buffer B for
6 min, from 48 to 80% buffer B for 1 min, and 80% buffer
B for 5 min.
Data analysis
Tandem mass spectra were retrieved using Xcalibur (ver-
sion 2.2, Thermo Fisher Scientific) and AnalystTF (ver-
sion 1.6, AB SCIEX) software. The MS/MS spectra files
were searched against the sequence database (72,672 en-
tries) using in-house PEAKS software (version 6.0, Bio-
informatics Solutions Inc.). The database was generated
from protein sequences of Apis (downloaded April 2012),
augmented with sequences from Sacharomyces cerevisiae
(downloaded April 2012), and a common repository of
adventitious proteins (cRAP, from The Global Proteome
Machine Organization, downloaded April 2012). The pre-
cursor and fragment mass tolerances were set to 50 ppm
and 0.05 Da, respectively; tryptic cleavage specificity
was set for up to two missed cleavages; carbamido-
methyl (C, +57.02) as a fixed modification; and oxida-
tion (M, +15.99) and deamidation (N, +0.98) as the onlyvariable modifications for the RJ sample and oxidation
(M, +15.99); deamidation (N, +0.98) and deamidation
18O (N, +2.998) for the glycopeptide enriched RJ sam-
ple. False discovery rate (FDR) was controlled using a
target/decoy database approach for both protein identi-
fication and modified peptide identification, applying
the cut-off FDR of 0.2%. Protein identification was ac-
cepted only if it contained at least two unique peptides.
All of the identified glycopeptides and assigned sites
were manually checked by applying the cut-off criteria:
PEAKS score (-log10P) > 30 and FDR < 0.2%, and the
majority of y or b ions could be detected with continu-
ous and strong intensity peaks. To localize protein to
the subcellular position, newly identified protein se-
quences were analyzed by PSORT II Prediction [30]
(http://psort.hgc.jp/form2.html). To verify the presence
of an N-terminal secretion signal peptide, the SignalP 4.1
Server [31] (http://www.cbs.dtu.dk/services/SignalP/) was
also used. The D-cut off for signal-TM networks was set
to 0.35. The putative functions of identified proteins and
glycoproteins were annotated by searching against the
Uniprot database (http://www.uniprot.org/) and grouped
on the basis of their molecular behavior and biological
process in gene ontology terms. All unique sequences of
N-glycopeptides were submitted online to WebLogo [86]
in order to extract the N-glycosylated site motif of RJ
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